ArticleHealth science reports2026
May-Thurner Syndrome: An Under-Recognized Etiology of Deep Vein Thrombosis (DVT).
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: May-Thurner Syndrome (MTS) is a rare vascular condition characterized by the compression of the left iliac vein by the overlying right iliac artery. This anatomical anomaly predisposes patients, especially young to middle-aged women, to deep vein thrombosis (DVT), which when it persists, leads to complications such as pulmonary embolism and chronic venous insufficiency. Despite its clinical significance, there is a lack of standardized guidelines for diagnosis and management. This review aims to summarize current knowledge on the epidemiology, pathophysiology, diagnostic approaches, and therapeutic strategies for MTS while highlighting challenges in establishing a consistent clinical framework. Methods: A comprehensive literature search was conducted using PubMed and Google Scholar, focusing on English-language studies involving human subjects. Sources included case reports, case series, clinical trials, systematic reviews, and expert consensus guidelines. Additional literature on iliac vein pathophysiology and venous thromboembolism management was reviewed to provide broader clinical context. Reference lists of key publications were manually examined for additional relevant studies. The final literature search was completed on April 5, 2025. Results: Common diagnostic methods for MTS include duplex ultrasound, CT venography, and MR venography, with intravascular ultrasound showing the highest sensitivity (> 98%). Endovascular stenting, often combined with catheter-directed thrombolysis, provides significant symptom relief and reduces post-thrombotic syndrome. In contrast, angioplasty alone was linked to higher recurrence rates. Long-term patency rates following stenting ranged from 79% to 100%. However, the absence of standardized diagnostic and treatment protocols contributes to variability in clinical outcomes. Conclusion: MTS remains an underrecognized cause of DVT, especially among young women. Although advances in diagnostic imaging and minimally invasive interventions have improved management, the lack of evidence-based guidelines continues to interfere with optimal care. Early diagnosis and individualized treatment plans are crucial, and further research is needed to establish evidence-based protocols for consistent management of MTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.